Medicare plans to negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities.

President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.

Treating initially unresectable gastric or GEJ cancer with camrelizumab plus nab-POF led to an R0 resection rate of 75% in a phase 2 trial.

Perioperative chemotherapy improved outcomes when compared to preoperative chemoradiotherapy in a phase 3 trial of patients with resectable esophageal cancer. Results from this tr ...

Adding evorpacept to treatment with trastuzumab, ramucirumab, and paclitaxel may improve outcomes in HER2-positive gastric/GEJ cancer.

Apologies can help improve the quality of the treatment relationship by restoring trust and sharing power with the patient.

(HealthDay News) — On Monday, President Donald Trump issued an executive order withdrawing the United States from the World Health Organization (WHO). The executive order retracts a Presidential ...

Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.

A growing body of research suggests that exposure to PFAS, commonly called "forever chemicals," may increase a person's risk ...

The lower payments female oncologists received may reflect a “disadvantage in terms of career trajectories for women,” according to researchers.

Under former President Joe Biden, enrollment in Medicaid hit a record high, and the uninsured rate reached a record low. President Donald Trump’s return to the White House — along with a ...

The FDA has approved Datroway (datopotamab deruxtecan) to treat adults with unresectable or metastatic, HR+, HER2- breast cancer who have received prior endocrine therapy and chemotherapy.